Correlation of haemostatic abnormalities with tumour stage and characteristics in dogs with mammary carcinoma.
Sixty female dogs with untreated mammary carcinoma, comprising equal numbers of dogs in tumour stages I to IV, were evaluated for haemostatic abnormalities using the following tests: platelet count, prothrombin time, activated partial thromboplastin time, thrombin time, plasma activity of factor V, VIII and X, plasma concentration of fibrinogen, fibrin monomers and fibrinogen degradation products, and plasma antithrombin III activity. Two-thirds of all dogs had one or more haemostatic test abnormality of which the likelihood and frequency was increased in those with stage III and IV neoplasia. Haemostatic abnormalities were more frequently observed in dogs which had mammary tumours with distant metastases, extended tumour necrosis, inflammatory carcinomas, tumours fixed to underlying structures, or tumours in which there was penetration of the tumour capsule by tumour cells. As in humans with mammary carcinoma, these haemostatic abnormalities might be used as prognostic indicators, but their clinical importance remains unknown.
Stockhaus
C
C
Klinik und Poliklinik für kleine Haustiere an der Freien Universität Berlin.
Kohn
B
B
Rudolph
R
R
Brunnberg
L
L
Giger
U
U
D000230:Adenocarcinoma / Q000097:blood / Q000473:pathology / Q000662:veterinary*; D000818:Animals; D001779:Blood Coagulation Factors / Q000302:isolation & purification; D001780:Blood Coagulation Tests; D002277:Carcinoma / Q000097:blood / Q000473:pathology / Q000662:veterinary*; D004283:Dog Diseases / Q000097:blood* / Q000473:pathology; D004285:Dogs; D005260:Female; D006487:Hemostasis; D015674:Mammary Neoplasms, Animal / Q000097:blood* / Q000473:pathology; D009367:Neoplasm Staging / Q000662:veterinary; D012016:Reference Values; D012306:Risk
D001779:Blood Coagulation Factors